Phase 3 Study of High-Dose Biotin, MD1003, for PPMS & SPMS
Posted: Fri May 19, 2017 6:27 am
HI Friends please read
https://multiplesclerosisnewstoday.com/ ... -patients/
A Phase 3 clinical trial has been launched by MedDay Pharmaceuticals to investigate whether treatment with high-dose biotin (MD1003) may ease disability and improve mobility in non-relapsing primary or secondary progressive MS patients. The study is recruiting participants across the U.S., Canada and Europe.
regards
seeva
https://multiplesclerosisnewstoday.com/ ... -patients/
A Phase 3 clinical trial has been launched by MedDay Pharmaceuticals to investigate whether treatment with high-dose biotin (MD1003) may ease disability and improve mobility in non-relapsing primary or secondary progressive MS patients. The study is recruiting participants across the U.S., Canada and Europe.
regards
seeva